Skip to main content
logo
Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
40.53
+0.02 (0.04%)
At close: Jul 24, 2026, 4:00 PM EDT
40.53
+0.01 (0.01%)
Pre-market: Jul 27, 2026, 4:50 AM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Development, Manufacture and Sale of Buprenorphine-Based Prescription Drugs
1.24B1.19B1.09B901.00M791.00M
Total
1.24B1.19B1.09B901.00M791.00M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
1.05B1.01B912.00M732.00M603.00M
Rest of World
186.00M179.00M181.00M169.00M181.00M
United Kingdom
----7.00M
Total
1.24B1.19B1.09B901.00M791.00M